Pan-cancer pharmacogenetics: Targeted sequencing panels or exome sequencing?
Laurentijn Tilleman graduated from the Faculty of Bioscience Engineering at Ghent University in 2016. He is now working on his PhD at Ghent University in the core facility for next generation sequencing (NXTGNT). His primary focus is on sequencing analysis in the field of pharmacogenomics.
In one of his recent publications, Laurentijn provides insight into some of the advantages of using IDT’s xGen™ Exome Hyb Panel for pharmacogenetics research studies. Click on the featured content below to learn more about his work and its findings!